Scientific Sessions 2025  /  Cardiovascular Precision Therapy is at the Bedside  /  Hyperlipidemia's Game-Changer: Can We Cure It with One Shot?
Logo

American Heart Association

  48
  0

Final ID:

Hyperlipidemia's Game-Changer: Can We Cure It with One Shot?

  • Rodriguez, Fatima  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
  • Knowles, Josh  ( Stanford University FALK CVRC , Stanford , California , United States )
  • Cuchel, Marina  ( UNIVERSITY OF PENNSYLVANIA , Narberth , Pennsylvania , United States )
    • Author Disclosures:
    Fatima Rodriguez: DO have relevant financial relationships ; Consultant:HealthPals:Past (completed) ; Consultant:Cleerly Health:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:iRhythm:Active (exists now) ; Consultant:HeartFlow:Active (exists now) ; Consultant:Arrowhead Pharmaceuticals:Active (exists now) ; Consultant:Edwards:Active (exists now) ; Consultant:Inclusive Health:Active (exists now) ; Consultant:Esperion Therapeutics:Past (completed) ; Consultant:Kento Health:Active (exists now) ; Consultant:Movano Health:Active (exists now) ; Consultant:NovoNordisk:Past (completed) ; Consultant:Novartis:Active (exists now) | Josh Knowles: DO NOT have relevant financial relationships | Marina Cuchel: DO have relevant financial relationships ; Consultant:Chiesi:Past (completed) ; Consultant:Ultragenyx:Past (completed) ; Consultant:Regeneron:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiovascular Precision Therapy is at the Bedside

Monday, 11/10/2025 , 03:15PM - 04:30PM

Main Event

More abstracts on this topic:
Gene Therapy at the Bedside: What Clinicians Need to Know

Helms Adam, Judge Daniel, Parikh Victoria

Gene Therapy for Heart Failure: From Bench to Bedside

Hajjar Roger, Rossano Joseph

More abstracts from these authors:
Gene Editing: An Effective and Durable Strategy for Lipid Disorders

Cuchel Marina, Hobbs Helen, Michos Erin

Prevalence of Familial Hypercholesteremia (FH) Among Participants in the ACCELERATE Trial: Implications for Opportunistic FH Screening and Prognostication

Sarraju Ashish, St John Julie, Singh Abhayjit, Knowles Josh, Rodriguez Fatima, Bruemmer Dennis, Cho Leslie, Xlaffinx Xlukex

You have to be authorized to contact abstract author. Please, Login
Not Available